Correlation Between ATT and Telo Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATT and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and Telo Genomics Corp, you can compare the effects of market volatilities on ATT and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and Telo Genomics.

Diversification Opportunities for ATT and Telo Genomics

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between ATT and Telo is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of ATT i.e., ATT and Telo Genomics go up and down completely randomly.

Pair Corralation between ATT and Telo Genomics

Taking into account the 90-day investment horizon ATT is expected to generate 3.26 times less return on investment than Telo Genomics. But when comparing it to its historical volatility, ATT Inc is 10.79 times less risky than Telo Genomics. It trades about 0.1 of its potential returns per unit of risk. Telo Genomics Corp is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  11.00  in Telo Genomics Corp on September 19, 2024 and sell it today you would lose (2.93) from holding Telo Genomics Corp or give up 26.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.44%
ValuesDaily Returns

ATT Inc  vs.  Telo Genomics Corp

 Performance 
       Timeline  
ATT Inc 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in ATT Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, ATT may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Telo Genomics Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Telo Genomics Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Telo Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

ATT and Telo Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATT and Telo Genomics

The main advantage of trading using opposite ATT and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.
The idea behind ATT Inc and Telo Genomics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.